I agree that this site is using cookies. You can find further informations here.
X
Terasaki, P. I.
651  results:
Search for persons X
?
1

Proposed Diagnostic Criteria for Chronic Antibody-Mediated ..:

O'Leary, J.G. ; Cai, J. ; Freeman, R....
American Journal of Transplantation.  16 (2016)  2 - p. 603-614 , 2016
Link: https://doi.org/10.1111/..
 
?
2

Impact of IgG3 Subclass and C1q-Fixing Donor-Specific HLA A..:

O'Leary, J.G. ; Kaneku, H. ; Banuelos, N....
American Journal of Transplantation.  15 (2015)  4 - p. 1003-1013 , 2015
Link: https://doi.org/10.1111/..
 
?
3

Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F ..:

Jucaud, V ; Ravindranath, M H ; Terasaki, P I...
Clinical and Experimental Immunology.  183 (2015)  3 - p. 326-340 , 2015
Link: https://doi.org/10.1111/..
 
?
4

Onset and progression of de novo donor‐specific anti‐human ..:

Dieplinger, G. ; Everly, M.J. ; Briley, K.P....
Transplant Infectious Disease.  17 (2015)  6 - p. 848-858 , 2015
Link: https://doi.org/10.1111/..
 
?
5

Immunoglobulin (Ig)G purified from human sera mirrors intra..:

Ravindranath, M H ; Terasaki, P I ; Maehara, C Y...
Clinical and Experimental Immunology.  179 (2015)  2 - p. 309-328 , 2015
Link: https://doi.org/10.1111/..
 
?
6

The Role of Donor-Specific HLA Alloantibodies in Liver Tran..:

O'Leary, J.G. ; Demetris, A.J. ; Friedman, L.S....
American Journal of Transplantation.  14 (2014)  4 - p. 779-787 , 2014
Link: https://doi.org/10.1111/..
 
?
7

Suppression of blastogenesis and proliferation of activated..:

Ravindranath, M H ; Terasaki, P I ; Pham, T..
Clinical and Experimental Immunology.  178 (2014)  1 - p. 154-177 , 2014
Link: https://doi.org/10.1111/..
 
?
8

Suppression of allo-human leucocyte antigen (HLA) antibodie..:

Zhu, D ; Ravindranath, M H ; Terasaki, P I...
Clinical and Experimental Immunology.  177 (2014)  2 - p. 464-477 , 2014
Link: https://doi.org/10.1111/..
 
?
9

Impact of the Presence and Duration of Donor-Specific Antib..:

Hoshino, J. ; Everly, M.J. ; Kaneku, H....
Transplantation Proceedings.  46 (2014)  1 - p. 75-80 , 2014
Link: https://doi.org/10.1016/..
 
?
10

24 HIGH MFI PREFORMED CLASS II DONOR SPECIFIC ANTIBODIES AC..:

O'Leary, J.G. ; Kaneku, H. ; Jennings, L.W....
Journal of Hepatology.  58 (2013)  - p. S11 , 2013
Link: https://doi.org/10.1016/..
 
?
11

De NovoDonor-Specific HLA Antibodies Decrease Patient and G..:

Kaneku, H. ; O'Leary, J. G. ; Banuelos, N....
American Journal of Transplantation.  , 2013
Link: https://doi.org/10.1002/..
 
?
12

De Novo Donor-Specific HLA Antibodies Decrease Patient and ..:

Kaneku, H. ; O'Leary, J.G. ; Banuelos, N....
American Journal of Transplantation.  13 (2013)  6 - p. 1541-1548 , 2013
Link: https://doi.org/10.1111/..
 
?
13

Higher Risk of Kidney Graft Failure in the Presence of Anti..:

Taniguchi, M. ; Rebellato, L.M. ; Cai, J....
American Journal of Transplantation.  13 (2013)  10 - p. 2577-2589 , 2013
Link: https://doi.org/10.1111/..
 
?
14

Cold Ischemia Time—Time to Rethink the Risk for Kidneys?:

Terasaki, P.I.
American Journal of Transplantation.  11 (2011)  12 - p. 2551-2552 , 2011
Link: https://doi.org/10.1111/..
 
?
15

High Mean Fluorescence Intensity Donor-Specific Anti-HLA An..:

O'Leary, J.G. ; Kaneku, H. ; Susskind, B.M....
American Journal of Transplantation.  11 (2011)  9 - p. 1868-1876 , 2011
Link: https://doi.org/10.1111/..
 
1-15